CLINICAL_TRIALS
trial_result
· 2010-01-27
Clinical Trial Update: Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. [Phase 1]
Summary
Phase 1 clinical trial of ixabepilone given as a 24-hour infusion in patients with solid malignancies; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: R-Pharm | Conditions: Solid Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2010-01-27